233 related articles for article (PubMed ID: 27472885)
1. ABCA7 Mediates Phagocytic Clearance of Amyloid-β in the Brain.
Fu Y; Hsiao JH; Paxinos G; Halliday GM; Kim WS
J Alzheimers Dis; 2016 Sep; 54(2):569-84. PubMed ID: 27472885
[TBL] [Abstract][Full Text] [Related]
2. Understanding the function of ABCA7 in Alzheimer's disease.
Li H; Karl T; Garner B
Biochem Soc Trans; 2015 Oct; 43(5):920-3. PubMed ID: 26517904
[TBL] [Abstract][Full Text] [Related]
3. Deletion of Abca7 increases cerebral amyloid-β accumulation in the J20 mouse model of Alzheimer's disease.
Kim WS; Li H; Ruberu K; Chan S; Elliott DA; Low JK; Cheng D; Karl T; Garner B
J Neurosci; 2013 Mar; 33(10):4387-94. PubMed ID: 23467355
[TBL] [Abstract][Full Text] [Related]
4. Genetic Variations in ABCA7 Can Increase Secreted Levels of Amyloid-β40 and Amyloid-β42 Peptides and ABCA7 Transcription in Cell Culture Models.
Bamji-Mirza M; Li Y; Najem D; Liu QY; Walker D; Lue LF; Stupak J; Chan K; Li J; Ghani M; Yang Z; Rogaeva E; Zhang W
J Alzheimers Dis; 2016 Jun; 53(3):875-92. PubMed ID: 27314524
[TBL] [Abstract][Full Text] [Related]
5. ABCA7 and Pathogenic Pathways of Alzheimer's Disease.
Aikawa T; Holm ML; Kanekiyo T
Brain Sci; 2018 Feb; 8(2):. PubMed ID: 29401741
[TBL] [Abstract][Full Text] [Related]
6. Study on Lentivirus-Mediated ABCA7 Improves Neurocognitive Function and Related Mechanisms in the C57BL/6 Mouse Model of Alzheimer's Disease.
Li M; Yuan Y; Hu B; Wu L
J Mol Neurosci; 2017 Apr; 61(4):489-497. PubMed ID: 28124230
[TBL] [Abstract][Full Text] [Related]
7. ABCA7 Downregulation Modifies Cellular Cholesterol Homeostasis and Decreases Amyloid-β Peptide Efflux in an in vitro Model of the Blood-Brain Barrier.
Lamartinière Y; Boucau MC; Dehouck L; Krohn M; Pahnke J; Candela P; Gosselet F; Fenart L
J Alzheimers Dis; 2018; 64(4):1195-1211. PubMed ID: 30010117
[TBL] [Abstract][Full Text] [Related]
8. Role of ABCA7 in Human Health and in Alzheimer's Disease.
Dib S; Pahnke J; Gosselet F
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925691
[TBL] [Abstract][Full Text] [Related]
9. ABCA7 Genotypes Confer Alzheimer's Disease Risk by Modulating Amyloid-β Pathology.
Zhao QF; Wan Y; Wang HF; Sun FR; Hao XK; Tan MS; Tan CC; Zhang DQ; Tan L; Yu JT;
J Alzheimers Dis; 2016 Mar; 52(2):693-703. PubMed ID: 27003212
[TBL] [Abstract][Full Text] [Related]
10. ABCA7 haplodeficiency disturbs microglial immune responses in the mouse brain.
Aikawa T; Ren Y; Yamazaki Y; Tachibana M; Johnson MR; Anderson CT; Martens YA; Holm ML; Asmann YW; Saito T; Saido TC; Fitzgerald ML; Bu G; Kanekiyo T
Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23790-23796. PubMed ID: 31690660
[TBL] [Abstract][Full Text] [Related]
11. ATP-binding cassette transporter A7 (ABCA7) loss of function alters Alzheimer amyloid processing.
Satoh K; Abe-Dohmae S; Yokoyama S; St George-Hyslop P; Fraser PE
J Biol Chem; 2015 Oct; 290(40):24152-65. PubMed ID: 26260791
[TBL] [Abstract][Full Text] [Related]
12. ABCA7-Associated Clinical Features and Molecular Mechanisms in Alzheimer's Disease.
Qian XH; Chen SY; Liu XL; Tang HD
Mol Neurobiol; 2023 Oct; 60(10):5548-5556. PubMed ID: 37322288
[TBL] [Abstract][Full Text] [Related]
13. Minocycline attenuates Aβ oligomers-induced pro-inflammatory phenotype in primary microglia while enhancing Aβ fibrils phagocytosis.
El-Shimy IA; Heikal OA; Hamdi N
Neurosci Lett; 2015 Nov; 609():36-41. PubMed ID: 26472705
[TBL] [Abstract][Full Text] [Related]
14. Differential Phagocytic Properties of CD45
Rangaraju S; Raza SA; Li NX; Betarbet R; Dammer EB; Duong D; Lah JJ; Seyfried NT; Levey AI
Front Immunol; 2018; 9():405. PubMed ID: 29552013
[TBL] [Abstract][Full Text] [Related]
15. The role of ABCA7 in Alzheimer's disease: evidence from genomics, transcriptomics and methylomics.
De Roeck A; Van Broeckhoven C; Sleegers K
Acta Neuropathol; 2019 Aug; 138(2):201-220. PubMed ID: 30903345
[TBL] [Abstract][Full Text] [Related]
16. Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer's mouse model: Implication of TLR4 signaling in disease progression.
Go M; Kou J; Lim JE; Yang J; Fukuchi KI
Biochem Biophys Res Commun; 2016 Oct; 479(2):331-337. PubMed ID: 27641666
[TBL] [Abstract][Full Text] [Related]
17. ATP-binding cassette transporter A7 enhances phagocytosis of apoptotic cells and associated ERK signaling in macrophages.
Jehle AW; Gardai SJ; Li S; Linsel-Nitschke P; Morimoto K; Janssen WJ; Vandivier RW; Wang N; Greenberg S; Dale BM; Qin C; Henson PM; Tall AR
J Cell Biol; 2006 Aug; 174(4):547-56. PubMed ID: 16908670
[TBL] [Abstract][Full Text] [Related]
18. Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism.
Koenigsknecht J; Landreth G
J Neurosci; 2004 Nov; 24(44):9838-46. PubMed ID: 15525768
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.
Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Li S; Ljubimov V; Moyseyev M; Daley D; Fuchs DT; Pham M; Black KL; Rentsendorj A; Koronyo-Hamaoui M
Brain; 2015 Aug; 138(Pt 8):2399-422. PubMed ID: 26049087
[TBL] [Abstract][Full Text] [Related]
20. Gantenerumab: a novel human anti-Aβ antibody demonstrates sustained cerebral amyloid-β binding and elicits cell-mediated removal of human amyloid-β.
Bohrmann B; Baumann K; Benz J; Gerber F; Huber W; Knoflach F; Messer J; Oroszlan K; Rauchenberger R; Richter WF; Rothe C; Urban M; Bardroff M; Winter M; Nordstedt C; Loetscher H
J Alzheimers Dis; 2012; 28(1):49-69. PubMed ID: 21955818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
